Medicare Enrolled
Dr. Victor Faradji, MD
Neurology · Miami, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Faradji from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Faradji? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Faradji
Dr. Victor Faradji is a neurology in Miami, FL, with 19 years in practice. Based on federal Medicare data, Dr. Faradji performed 985 Medicare services across 757 unique beneficiaries.
Between the years covered by Open Payments, Dr. Faradji received a total of $33,258 from 93 pharmaceutical and/or device companies across 1305 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Faradji is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 31% volume in FL$ $33,258 industry payments
Medicare Practice Summary
Medicare Utilization ↗985
Medicare services
Top 31% in FL for neurology
757
Unique beneficiaries
$123
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~52 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) | 214 | $150 | $788 |
| Office visit, established patient (30-39 min) | 170 | $103 | $562 |
| Needle measurement of electrical activity in arm or leg muscles, complete study | 99 | $80 | $433 |
| Annual depression screening | 76 | $19 | $77 |
| Nerve conduction, 9-10 studies | 72 | $173 | $955 |
| New patient office visit, complex (60-74 min) | 55 | $177 | $976 |
| Measurement of brain wave activity (eeg), awake and drowsy | 45 | $310 | $1,599 |
| New patient office visit (45-59 min) | 41 | $127 | $730 |
| Administration of psychological or neuropsychological test by technician, each additional 30 minutes | 40 | $28 | $155 |
| Needle measurement of electrical activity in arm or leg muscles, limited study | 37 | $53 | $280 |
| EEG, extended monitoring | 21 | $368 | $1,914 |
| Ultrasound of both sides of head and neck blood flow | 19 | $162 | $1,037 |
| Test to assess balance during warm and cool irrigation in both ears | 18 | $33 | $177 |
| Evaluation and testing for balance with recording | 18 | $90 | $465 |
| Evaluation of brain response to sound for determination of hearing threshold with interpretation and report | 18 | $95 | $505 |
| Evaluation of neuropsychological test, first hour | 14 | $100 | $560 |
| Evaluation of neuropsychological test, each additional hour | 14 | $81 | $433 |
| Administration of psychological or neuropsychological test by technician, first 30 minutes | 14 | $28 | $156 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$33,258
Total received (2018-2024)
Avg $4,751/year across 7 years
Top 11% in FL for neurology
93
Companies
1,305
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$32,355 (97.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$642 (1.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$261 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$5,902
2023$4,596
2022$4,026
2021$3,198
2020$3,246
2019$6,215
2018$6,076
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$2,899
Amgen Inc.
$2,515
UCB, Inc.
$1,932
Teva Pharmaceuticals USA, Inc.
$1,778
Eli Lilly and Company
$1,438
Alexion Pharmaceuticals, Inc.
$1,409
Lilly USA, LLC
$1,250
Allergan Inc.
$1,151
Eisai Inc.
$1,140
ACADIA Pharmaceuticals Inc
$981
Biogen, Inc.
$913
PFIZER INC.
$848
Neurocrine Biosciences, Inc.
$848
ARGENX US, INC.
$665
Promius Pharma LLC
$658
Lundbeck LLC
$637
Novartis Pharmaceuticals Corporation
$596
GENZYME CORPORATION
$564
Avanir Pharmaceuticals, Inc.
$535
Allergan, Inc.
$534
AbbVie Inc.
$533
Sunovion Pharmaceuticals Inc.
$494
Adamas Pharmaceuticals, Inc.
$477
US WorldMeds, LLC
$404
Acorda Therapeutics, Inc
$396
Amneal Pharmaceuticals LLC
$396
Supernus Pharmaceuticals, Inc.
$308
IMPEL PHARMACEUTICALS INC.
$296
Neurelis, Inc.
$275
EMD Serono, Inc.
$268
Kyowa Kirin, Inc.
$264
Biohaven Pharmaceutical Holding Company Ltd.
$229
Inspire Medical Systems, Inc.
$221
Merz Pharmaceuticals, LLC
$213
SK Life Science, Inc.
$212
MITSUBISHI TANABE PHARMA AMERICA, INC.
$209
Otsuka America Pharmaceutical, Inc.
$204
Upsher-Smith Laboratories LLC
$203
Grifols USA, LLC
$192
Mitsubishi Tanabe Pharma America, Inc.
$187
Biohaven Pharmaceuticals, Inc.
$186
Almatica Pharma LLC
$181
SCILEX PHARMACEUTICALS INC.
$179
Alnylam Pharmaceuticals Inc.
$167
Scilex Pharmaceuticals Inc.
$157
Akcea Therapeutics, Inc.
$148
Zyla Life Sciences
$148
Boston Scientific Corporation
$146
Averitas Pharma Inc.
$135
Corium, LLC
$130
Mallinckrodt Hospital Products Inc.
$128
Janssen Pharmaceuticals, Inc
$128
IDORSIA PHARMACEUTICALS US INC
$127
Novo Nordisk Inc
$125
CSL Behring
$107
Alfasigma USA, Inc.
$107
AstraZeneca Pharmaceuticals LP
$101
Avion Pharmaceuticals
$96
Mallinckrodt LLC
$95
Bausch Health US, LLC
$95
MDD US Operations, LLC
$88
REVANCE THERAPEUTICS, INC.
$75
EISAI INC.
$70
GRT US Holding, Inc.
$65
Assertio Therapeutics, Inc.
$62
Takeda Pharmaceuticals U.S.A., Inc.
$56
Egalet US Inc
$56
LivaNova USA, Inc.
$56
Impax Laboratories, Inc.
$52
Piramal Imaging Limited
$50
Harmony Biosciences Llc
$50
Harmony Biosciences LLC
$47
UPSHER-SMITH LABORATORIES LLC
$46
NS Pharma, Inc.
$45
Ipsen Biopharmaceuticals, Inc
$44
Vertical Pharmaceuticals, LLC
$41
Shire North American Group Inc
$33
Zyla Life Sciences, Inc.
$32
BANNER LIFE SCIENCES, LLC
$32
GE HealthCare
$31
TerSera Therapeutics LLC
$31
ASSERTIO THERAPEUTICS, Inc.
$30
GE HEALTHCARE
$26
Arbor Pharmaceuticals, Inc.
$23
Horizon Therapeutics plc
$21
Bayer HealthCare Pharmaceuticals Inc.
$20
Jazz Pharmaceuticals Inc.
$19
Sumitomo Pharma America, Inc.
$18
ARBOR PHARMACEUTICALS, INC.
$18
Genentech USA, Inc.
$16
ASSERTIO THERAPEUTICS, INC.
$15
Aprecia Pharmaceuticals, LLC
$14
Life Molecular Imaging Ltd
$14
Top 3 companies account for 22.1% of total payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Apokyn · Austedo XR · Azstarys · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · Betaseron · Briviact · CAMBIA · CITALOPRAM · COMIRNATY · COPAXONE · CREXONT · Cambia · DAXXIFY · DUOPA · Dhivy · Dysport · EMGALITY · ERGOMAR · Fintepla · Fycompa · GAMMAGARD · GILENYA · GOCOVRI · GRALISE · Gamunex-C · Gralise · Hizentra · Horizant · INBRIJA · INGREZZA · INSPIRE · KESIMPTA · KISUNLA · LEMTRADA · LOREEV XR · LORZONE · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · NAMZARIC · NAPRELAN · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · OSMOLEX ER · Ongentys · PAXLOVID · POMPE - DISEASE · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUTENZA · QUVIVIQ · Qutenza · RADICAVA · REXULTI · RYTARY · Radicava · Rebif · Repatha · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · Soliris · Spritam · TECFIDERA · TEGSEDI · TOPIRAMATE Extended Release Capsules · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VIIBRYD · VILTEPSO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VUMERITY · VYALEV · VYEPTI · VYVANSE · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · WAKIX · WATCHMAN · Xadago · Xeomin · Xyrem · ZEMBRACE SYMTOUCH · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $3,376 per 100 Medicare services performed
Geographic Context
Neurologys within 10 mi
220
Per 100K population
8.2
County median income
$68,694
Nearest hospital
BAPTIST HOSPITAL OF MIAMI
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Faradji is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (low-engagement, top 11%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Faradji experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Faradji performed 214 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Faradji receive payments from pharmaceutical companies?
Yes. Dr. Faradji received a total of $33,258 from 93 companies across 1,305 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Faradji's costs compare to other neurologys in Miami?
Dr. Faradji's average Medicare payment per service is $123. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Faradji) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologys in Miami
Browse neurologys in Miami ranked by procedure volume and transparency data.
Highest volume
Top Neurologys in FL
Neurologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologys in FL
Which FL neurologys receive the most from drug and device companies.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology